Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Pfizer Stock Rose Today

TheMotleyFool

0 0

Shares of Pfizer (NYSE: PFE) rose 3.2% on Wednesday after the pharmaceutical giant released promising early results from its COVID-19 vaccine trials.

Pfizer is working with German biotech BioNTech (NASDAQ: BNTX) to develop a novel coronavirus vaccine. On Wednesday, the two companies said that one of their vaccine candidates, labeled BNT162b1, produced neutralizing antibodies in all 24 participants who received two doses (of either 10 or 30 micrograms) of the experimental drug. Health officials are hopeful that neutralizing antibodies could help to build immunity to COVID-19.

Pfizer and BioNTech released positive preliminary data from their coronavirus vaccine study on Wednesday. Image source: Getty Images.

Source Fool.com

Like: 0

PFE

Share